Quarterly report pursuant to Section 13 or 15(d)

Warrants (Tables)

v3.20.4
Warrants (Tables)
3 Months Ended
Dec. 31, 2020
Warrants And Rights Note Disclosure [Abstract]  
Summary of Warrant Activity

The following table summarizes information about the Company’s warrants at December 31, 2020 and September 30, 2020, respectively:

 

 

 

Number of units -

Series B Convertible

preferred warrants

 

 

Weighted Average

Exercise Price

 

 

Weighted Average

Remaining Contractual

Term (in years)

 

 

Intrinsic Value

 

Outstanding and Exercisable at September 30, 2020

 

 

118,029

 

 

$

20.80

 

 

 

1.35

 

 

$

 

Outstanding and Exercisable at December 31, 2020

 

 

118,029

 

 

$

20.80

 

 

 

1.10

 

 

$

 

Summary of Information Assuming Warrants are Exercised and Exchanged for Common Shares

The warrants may be exchanged for shares of common stock at a ratio of one share of Series B Preferred Stock into five common shares. The following table provides information assuming the warrants are exercised and exchanged for common shares:

 

 

 

Number of units -

Series B Convertible

preferred warrants

 

 

Weighted Average

Exercise Price

 

 

Weighted Average

Remaining Contractual

Term (in years)

 

 

Intrinsic Value

 

Outstanding and Exercisable at September 30, 2020

 

 

590,147

 

 

$

4.16

 

 

 

1.35

 

 

$

2,820

 

Outstanding and Exercisable at December 31, 2020

 

 

590,147

 

 

$

4.16

 

 

 

1.10

 

 

$

4,874

 

Summary of Warrants Outstanding and Exercisable

The exercise price for the Series B Convertible Preferred Stock warrants outstanding and exercisable at December 31, 2020 and September 30, 2020, are as follows:

 

Series B Convertible Preferred

 

Outstanding and Exercisable

 

Number of Warrants

 

 

Exercise Price

 

 

54,396

 

 

$

16.60

 

 

17,857

 

 

 

16.80

 

 

12,383

 

 

 

24.30

 

 

33,393

 

 

 

28.50

 

 

118,029